top-header

menu

news

News from the world

27

May

No Near-Term Impact on Chinese API Makers as Pharma Supply-Chain Shifts

Chinese active pharmaceutical ingredient (API) makers are unlikely to be significantly affected in the medium term by increasing trade protectionism and customer moves to reduce dependence on supplies from China, Fitch Ratings says. However, API makers with high exposure to India may lose customers because of the country's initiatives to reduce reliance on Chinese API...[FitchRating]

03

Jul

Generici e biosimilari. Presentato alle Istituzioni il “Manifesto per la ripartenza”

Una nuova politica industriale che garantisca sostenibilità al comparto pharma, assicurando a tutte le sue componenti regole chiare, certe e semplificate e ridia maggiore autonomia e capacità...

30

Jun

The COVID-19 Pandemic Sheds Light on the Over-Reliance on Offshore Drug Manufacturers

Four ideas to bring drug substance and drug product manufacturing back to the U.S....[ContractPharma]

30

Jun

Active Pharmaceutical Ingredients: How dependent is India on China

Despite calls to reduce imports from China, India's reliance on its hostile neighbour for the pharmaceutical sector remains. At least 60% of India's Active Pharmaceutical Ingredient (API) requirements...

26

Jun

EMA nominates executive director to replace Rasi

The European Medicines Agency’s (EMA) Management Board on Thursday nominated Emer Cooke from a short list of candidates to succeed Guido Rasi as the agency’s next executive director...[EMA]

slider-banner

home-footer
pager